InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: daemon57 post# 123447

Wednesday, 10/14/2020 5:14:22 PM

Wednesday, October 14, 2020 5:14:22 PM

Post# of 233142
Thinking about our Phase 2 study with M/M , and 64 S/C eIND patients , I am convinced that our interim results will be very good .

I am sure they will not stop our study because of side effects , or because we will have no effect on this disease at all...

I believe that we will have much better results then Remdesivir , when their study was stopped and drug received EUA.
And as PSea added we even reduced better viral load then antiviral Remdesivir...

Will they give us EUA , we don't know , but the worse will be that we will need few more months to finish study , they will accelerate enrollment , England will be added , and in few months we will have REGULAR approval not only EUA ..With regular approval doctors may start to use drug off label.

In the mean time we might get EUA in Philippine , England , EU and some other places ..
Or just some interesting licensing , or even BO , I never will exclude this...

When I see some studies are stopped because drug is not working or because of severe side effects , I always think of shareholders , they have a reason to worry ,
So far our drug work well wherever we tried , and not one serious side effect ever so far ..

I guess after 5 years I evaluate things differently.

My best to all.

And all IMO as always.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News